Key result
Baseline history of cardiac failure (p=0.027), smaller left atrial area (p=0.010), and longer QT(tang) minus QT(top) interval (p<0.001) predicted drug-related morphological T wave changes.
Why the study?
Do baseline clinical and ECG characteristics predict morphological T wave changes in patients receiving a combined potassium and sodium channel blocking agent for atrial fibrillation?
Observational (n=145)
Do baseline clinical and ECG characteristics predict morphological T wave changes in patients receiving a combined potassium and sodium channel blocking agent for atrial fibrillation?
Baseline clinical and ECG parameters, including history of heart failure and specific QT intervals, can predict drug-induced morphological T wave changes in AF patients.
OBJECTIVES: To describe the characteristics of patients presenting with morphological T wave changes that lead to measurement difficulties, and to identify possible predictors of such changes at baseline and early after start of treatment. DESIGN: ECGs from 145 patients receiving a combined potassium and sodium channel blocking agent for conversion of atrial fibrillation (AF), underwent semiautomatic analysis in a digitalized high-precision analysis program. In 15 patients, one or more ECGs were identified as difficult to interpret due to morphological T wave changes. They were compared with the 130 patients without such changes. RESULTS: A history of cardiac failure (p=0.027), a smaller left atrial area (p=0.010) and a longer QT(tang) minus QT(top) interval (p<0.001) at baseline was significantly more frequent as compared to the controls. Identified patients also had somewhat longer baseline QT interval duration (median QT(cB) 432 vs. 408 ms, N.S.) and a larger proportion of them were females (47% vs. 27%, N.S.). After start of infusion the QT(cB) became significantly longer in identified patients than in controls (p=0.012). CONCLUSIONS: Independent predictors of subsequent morphological changes were found at baseline and shortly after start of treatment, and may be of use to identify individuals with a reduced repolarization reserve.
No takes yet. Share an insight, caveat, or question.
Tjäderborn et al. (2010) conducted an observational in Atrial fibrillation (n=145). Combined potassium and sodium channel blocking agent was evaluated on Morphological T wave changes leading to measurement difficulties. Baseline history of cardiac failure (p=0.027), smaller left atrial area (p=0.010), and longer QT(tang) minus QT(top) interval (p<0.001) predicted drug-related morphological T wave changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: